Back
Moderna, Inc. 10K Form
Sell
45
MRNA
Moderna, Inc.
Last Price:
$57.83
Seasonality Move:
18.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRNA News And Ratings
See the #1 stock for the next 7 days that we like better than MRNA
MRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.9B |
|---|---|
| Cash Flow: | $891M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $21.95 |
| Price / Book: | 2.64 |
Profitability
| EPS (TTM): | -7.26170 |
|---|---|
| Net Income (TTM): | $-2.8B |
| Gross Margin: | $861M |
| Return on Equity: | -29.19% |
| Return on Assets: | -22.28% |
Moderna, Inc. Earnings Forecast
Key Moderna, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for MRNA is 44.29%.
-
The Selling, General & Administrative Expenses for MRNA have been equal to 52.37% of Gross Profit Margin.
-
The Research & Development expenses have been 150.05% of Revenue.
-
The Net Earning history of MRNA is -145.16% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 4 years.
Moderna, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRNA |
| CUSIP: | 60770K |
| Website: | modernatx.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 3.29 |
| Quick Ratio: | 3.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MRNA Technical Analysis vs Fundamental Analysis
Sell
45
Moderna, Inc. (MRNA)
is a Sell
Is Moderna, Inc. a Buy or a Sell?
-
Moderna, Inc. stock is rated a SellThe current Moderna, Inc. [MRNA] share price is $57.80. The Score for MRNA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.